Global Oncolytic Virus Therapy Market Size, Status and Forecast 2022

Global Oncolytic Virus Therapy Market Size, Status and Forecast 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2016-2027)
2.2 Oncolytic Virus Therapy Growth Trends by Regions
2.2.1 Oncolytic Virus Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncolytic Virus Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Oncolytic Virus Therapy Industry Dynamic
2.3.1 Oncolytic Virus Therapy Market Trends
2.3.2 Oncolytic Virus Therapy Market Drivers
2.3.3 Oncolytic Virus Therapy Market Challenges
2.3.4 Oncolytic Virus Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Therapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2016-2021)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2020
3.5 Oncolytic Virus Therapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Therapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Therapy Breakdown Data by Type
4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2016-2021)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2022-2027)
5 Oncolytic Virus Therapy Breakdown Data by Application
5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2016-2021)
5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oncolytic Virus Therapy Market Size (2016-2027)
6.2 North America Oncolytic Virus Therapy Market Size by Type
6.2.1 North America Oncolytic Virus Therapy Market Size by Type (2016-2021)
6.2.2 North America Oncolytic Virus Therapy Market Size by Type (2022-2027)
6.2.3 North America Oncolytic Virus Therapy Market Size by Type (2016-2027)
6.3 North America Oncolytic Virus Therapy Market Size by Application
6.3.1 North America Oncolytic Virus Therapy Market Size by Application (2016-2021)
6.3.2 North America Oncolytic Virus Therapy Market Size by Application (2022-2027)
6.3.3 North America Oncolytic Virus Therapy Market Size by Application (2016-2027)
6.4 North America Oncolytic Virus Therapy Market Size by Country
6.4.1 North America Oncolytic Virus Therapy Market Size by Country (2016-2021)
6.4.2 North America Oncolytic Virus Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size (2016-2027)
7.2 Europe Oncolytic Virus Therapy Market Size by Type
7.2.1 Europe Oncolytic Virus Therapy Market Size by Type (2016-2021)
7.2.2 Europe Oncolytic Virus Therapy Market Size by Type (2022-2027)
7.2.3 Europe Oncolytic Virus Therapy Market Size by Type (2016-2027)
7.3 Europe Oncolytic Virus Therapy Market Size by Application
7.3.1 Europe Oncolytic Virus Therapy Market Size by Application (2016-2021)
7.3.2 Europe Oncolytic Virus Therapy Market Size by Application (2022-2027)
7.3.3 Europe Oncolytic Virus Therapy Market Size by Application (2016-2027)
7.4 Europe Oncolytic Virus Therapy Market Size by Country
7.4.1 Europe Oncolytic Virus Therapy Market Size by Country (2016-2021)
7.4.2 Europe Oncolytic Virus Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2016-2027)
8.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Type
8.2.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Application
8.3.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region
8.4.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size (2016-2027)
9.2 Latin America Oncolytic Virus Therapy Market Size by Type
9.2.1 Latin America Oncolytic Virus Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Oncolytic Virus Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Oncolytic Virus Therapy Market Size by Type (2016-2027)
9.3 Latin America Oncolytic Virus Therapy Market Size by Application
9.3.1 Latin America Oncolytic Virus Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Oncolytic Virus Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Oncolytic Virus Therapy Market Size by Application (2016-2027)
9.4 Latin America Oncolytic Virus Therapy Market Size by Country
9.4.1 Latin America Oncolytic Virus Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Oncolytic Virus Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2016-2027)
10.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type
10.2.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application
10.3.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country
10.4.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Therapy Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Details
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Details
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Therapy Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Details
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Details
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Details
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Therapy Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Details
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Details
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Details
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Details
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Details
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Details
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Therapy Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Details
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Details
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2016-2021)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HSV-based Oncolytic Viruses
Table 3. Key Players of Adenoviruses-based Oncolytic Viruses
Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses
Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oncolytic Virus Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Oncolytic Virus Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Oncolytic Virus Therapy Market Share by Regions (2016-2021)
Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Oncolytic Virus Therapy Market Share by Regions (2022-2027)
Table 13. Oncolytic Virus Therapy Market Trends
Table 14. Oncolytic Virus Therapy Market Drivers
Table 15. Oncolytic Virus Therapy Market Challenges
Table 16. Oncolytic Virus Therapy Market Restraints
Table 17. Global Oncolytic Virus Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Oncolytic Virus Therapy Market Share by Players (2016-2021)
Table 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Therapy as of 2020)
Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncolytic Virus Therapy Product Solution and Service
Table 24. Date of Enter into Oncolytic Virus Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2016-2021)
Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Oncolytic Virus Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2016-2021)
Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Oncolytic Virus Therapy Product
Table 67. Amgen Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Oncolytics Biotech Company Details
Table 70. Oncolytics Biotech Business Overview
Table 71. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 72. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 73. Oncolytics Biotech Recent Development
Table 74. Viralytics Company Details
Table 75. Viralytics Business Overview
Table 76. Viralytics Oncolytic Virus Therapy Product
Table 77. Viralytics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 78. Viralytics Recent Development
Table 79. Transgene SA Company Details
Table 80. Transgene SA Business Overview
Table 81. Transgene SA Oncolytic Virus Therapy Product
Table 82. Transgene SA Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 83. Transgene SA Recent Development
Table 84. Oncolys BioPharma Company Details
Table 85. Oncolys BioPharma Business Overview
Table 86. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 87. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 88. Oncolys BioPharma Recent Development
Table 89. Targovax Company Details
Table 90. Targovax Business Overview
Table 91. Targovax Oncolytic Virus Therapy Product
Table 92. Targovax Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 93. Targovax Recent Development
Table 94. PsiOxus Therapeutics Company Details
Table 95. PsiOxus Therapeutics Business Overview
Table 96. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 97. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 98. PsiOxus Therapeutics Recent Development
Table 99. SillaJen Biotherapeutics Company Details
Table 100. SillaJen Biotherapeutics Business Overview
Table 101. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 102. SillaJen Biotherapeutics Recent Development
Table 103. Sorrento Therapeutics Company Details
Table 104. Sorrento Therapeutics Business Overview
Table 105. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 106. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 107. Sorrento Therapeutics Recent Development
Table 108. Lokon Pharma Company Details
Table 109. Lokon Pharma Business Overview
Table 110. Lokon Pharma Oncolytic Virus Therapy Product
Table 111. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 112. Lokon Pharma Recent Development
Table 113. Genelux Corporation Company Details
Table 114. Genelux Corporation Business Overview
Table 115. Genelux Corporation Oncolytic Virus Therapy Product
Table 116. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 117. Genelux Corporation Recent Development
Table 118. Vyriad Company Details
Table 119. Vyriad Business Overview
Table 120. Vyriad Oncolytic Virus Therapy Product
Table 121. Vyriad Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 122. Vyriad Recent Development
Table 123. TILT Biotherapeutics Company Details
Table 124. TILT Biotherapeutics Business Overview
Table 125. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 126. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 127. TILT Biotherapeutics Recent Development
Table 128. Cold Genesys Company Details
Table 129. Cold Genesys Business Overview
Table 130. Cold Genesys Oncolytic Virus Therapy Product
Table 131. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
Table 132. Cold Genesys Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Therapy Market Share by Type: 2020 VS 2027
Figure 2. HSV-based Oncolytic Viruses Features
Figure 3. Adenoviruses-based Oncolytic Viruses Features
Figure 4. Vaccinia Virus-based Oncolytic Viruses Features
Figure 5. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 6. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 7. Global Oncolytic Virus Therapy Market Share by Application: 2020 VS 2027
Figure 8. Melanoma Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Oncolytic Virus Therapy Report Years Considered
Figure 14. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Oncolytic Virus Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Oncolytic Virus Therapy Market Share by Regions: 2020 VS 2027
Figure 17. Global Oncolytic Virus Therapy Market Share by Regions (2022-2027)
Figure 18. Global Oncolytic Virus Therapy Market Share by Players in 2020
Figure 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Therapy as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2020
Figure 21. Global Oncolytic Virus Therapy Revenue Market Share by Type (2016-2021)
Figure 22. Global Oncolytic Virus Therapy Revenue Market Share by Type (2022-2027)
Figure 23. North America Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Oncolytic Virus Therapy Market Share by Type (2016-2027)
Figure 25. North America Oncolytic Virus Therapy Market Share by Application (2016-2027)
Figure 26. North America Oncolytic Virus Therapy Market Share by Country (2016-2027)
Figure 27. United States Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Oncolytic Virus Therapy Market Share by Type (2016-2027)
Figure 31. Europe Oncolytic Virus Therapy Market Share by Application (2016-2027)
Figure 32. Europe Oncolytic Virus Therapy Market Share by Country (2016-2027)
Figure 33. Germany Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Oncolytic Virus Therapy Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Oncolytic Virus Therapy Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2016-2027)
Figure 43. China Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Oncolytic Virus Therapy Market Share by Type (2016-2027)
Figure 51. Latin America Oncolytic Virus Therapy Market Share by Application (2016-2027)
Figure 52. Latin America Oncolytic Virus Therapy Market Share by Country (2016-2027)
Figure 53. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Oncolytic Virus Therapy Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Oncolytic Virus Therapy Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2016-2027)
Figure 59. Turkey Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 63. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 64. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 65. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 66. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 67. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 68. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 69. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 70. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 71. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 72. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 73. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 74. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 75. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs